Mapping COVID-19 functional sequelae: the perspective of nuclear medicine

Simone Cristina Soares Brandão1, Júlia de Oliveira Xavier Ramos2, Gustavo Freitas Alves de Arruda2

  • 1Department of Internal Medicine, Divisions of Cardiology and Nuclear Imaging, Hospital das Clínicas, Federal University of Pernambuco (UFPE) Recife, PE, Brazil.

Insights

Nuclear Medicine imaging can detect and monitor organ damage caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). These techniques are crucial for evaluating lung and non-lung sequelae after coronavirus disease 2019 (COVID-19).

Area of Science:

  • Nuclear Medicine
  • Infectious Diseases
  • Cardiovascular Imaging
  • Pulmonary Imaging
  • Nephrology
  • Vascular Biology

Background:

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can lead to multi-organ damage through various mechanisms including direct viral toxicity, inflammation, and endothelial dysfunction.
  • Lung, heart, kidney, and endothelium impairment are prominent in severe cases of coronavirus disease 2019 (COVID-19).
  • Monitoring the long-term effects and sequelae of COVID-19 is essential for patient management.

Purpose of the Study:

  • To review the application of Nuclear Medicine techniques in the detection and monitoring of organ damage following SARS-CoV-2 infection.
  • To highlight the role of Nuclear Medicine in assessing pulmonary and extrapulmonary sequelae of COVID-19.
  • To discuss the therapeutic evaluation of COVID-19 sequelae using advanced imaging modalities.

Main Methods:

  • Utilizing accurate and safe Nuclear Medicine examinations such as Positron Emission Tomography-Computed Tomography (PET-CT) and scintigraphy.
  • Employing appropriate radiopharmaceuticals to analyze organ-specific inflammation, fibrosis, perfusion, and function.
  • Assessing the anatomophysiological status of multiple human organ systems.

Main Results:

  • Nuclear Medicine imaging allows for detailed assessment of organ systems affected by SARS-CoV-2.
  • These techniques can identify and quantify inflammation, fibrosis, and functional changes in organs like the lungs, heart, and kidneys.
  • The study emphasizes the potential for Nuclear Medicine to track disease progression and treatment response in COVID-19 patients.

Conclusions:

  • Nuclear Medicine offers valuable tools for the comprehensive evaluation of COVID-19 related organ damage and sequelae.
  • Its application is critical for monitoring patients, especially those with persistent pulmonary and extrapulmonary manifestations.
  • These imaging modalities support therapeutic decision-making and evaluation in the management of post-COVID-19 conditions.

Related Concept Videos

Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
269
Biological Effects of Radiation02:59

Biological Effects of Radiation

All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
16.9K
Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.6K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
330
Radiological Investigation II: MRI and Ventilation Perfusion Scan01:30

Radiological Investigation II: MRI and Ventilation Perfusion Scan

Description
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...
341